OR WAIT null SECS
September 28, 2018
Specialist biopharmaceutical company, Alvotech, has announced receipt of a manufacturing license from the Icelandic Medicines Agency, applying to its biopharmaceutical facility based in Reykjavik, Iceland.
While food, shelter, and clothing are the primal essentials for life, hope-as embodied by modern medicine-has now become part of that human expectation.
September 13, 2018
The collaboration will focus on developing manufacturing solutions for biosimilars.
July 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
July 01, 2018
Biosimilars and biobetters face developmental challenges to achieving commercialization.
June 15, 2018
Biosimilars and biobetters have their own unique manufacturing strategies and challenges.
May 29, 2018
The European Commission has approved Zessly (infliximab), a biosimilar to Johnson & Johnson’s blockbuster Remicade (infliximab).
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.
April 09, 2018
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
April 05, 2018
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.